Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer.

Thomas KolbenLena MüllerSarah MeisterLucia KeilmannChristina BuschmannFabian TrillschAlexander BurgesBastian CzogallaSophie MitterElisa SchmoeckelStefanie CorradiniSven MahnerUdo JeschkeMirjana KesslerSusanne Beyer

Published in: Journal of cancer research and clinical oncology (2022)

This is the first study examining the expression of SLeX, SLeA and LeY in EC, which can serve as additional future prognostic markers. Further studies are necessary to understand the underlying mechanisms. The study was approved by the local ethics committee of the Ludwig-Maximilians University Munich (reference number 19-249).

Keyphrases

endometrial cancer
public health
poor prognosis
dendritic cells
machine learning